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ABSTRACT
Background: After meal ingestion, a series of coordinated hormone responses occur concomitantly with changes in
perceived appetite. It is not known whether interindividual variability in appetite exists in response to a meal.
Objectives: The aim of this study was to 1) assess the reproducibility of appetite responses to a meal; 2) quantify
individual differences in responses; and 3) explore any moderating influence of the fat mass and obesity associated
(FTO) gene.
Methods: Using a replicated crossover design, 18 healthy men (mean ± SD age: 28.5 ± 9.8 y; BMI: 27.0 ±
5.0 kg/m2) recruited according to FTO genotype (9 AA, 9 TT) completed 2 identical control and 2 identical standardized
meal conditions (5025 kJ) in randomized sequences. Perceived appetite and plasma acylated ghrelin, total peptide
YY (PYY), insulin, and glucose concentrations were measured before and after interventions as primary outcomes.
Interindividual differences were explored using Pearson’s product-moment correlations between the first and second
replicates of the control-adjusted meal response. Within-participant covariate-adjusted linear mixed models were used
to quantify participant-by-condition and genotype-by-condition interactions.
Results: The meal suppressed acylated ghrelin and appetite perceptions [standardized effect size (ES): 0.18–4.26] and
elevated total PYY, insulin, and glucose (ES: 1.96–21.60). For all variables, SD of change scores was greater in the meal
than in the control conditions. Moderate-to-large positive correlations were observed between the 2 replicates of control-
adjusted meal responses for all variables (r = 0.44–0.86, P ≤ 0.070). Participant-by-condition interactions were present
for all variables (P ≤ 0.056). FTO genotype-by-condition interactions were nonsignificant (P ≥ 0.19) and treatment effect
differences between genotype groups were small (ES ≤ 0.27) for all appetite parameters.
Conclusions: Reproducibility of postprandial appetite responses is generally good. True interindividual variability is
present beyond any randomwithin-subject variation in healthymen but we detected nomoderation by the FTO genotype.
These findings highlight the importance of exploring individual differences in appetite for the prevention and treatment
of obesity. This trial was registered at clinicaltrials.gov as NCT03771690. J Nutr 2019;149:1159–1169.
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Introduction
Interindividual variability in response to an intervention, in-
cluding manipulations of dietary intake and exercise energy ex-
penditure, has received considerable interest from the scientific
community in recent years (1–3). The notion that individuals
may differ in the magnitude of response to an identical stimulus
has widespread implications, and the potential to engender
tailored strategies that optimize health outcomes for individuals
is undoubtedly appealing (4). Within this sphere, an increasing
number of studies have been undertaken to quantify individual
differences in appetite and energy intake responses to an inter-
vention (5, 6). Specifically, marked individual variability in ad
libitum energy intake has been reported in response to a single
bout of cycling (5); however, recent evidence from a large pooled
data set suggests that such variability can be explained by nor-
mal day-to-day variation in most cases (6). This line of enquiry
has direct implications for energy balance and weight control.
The consumption of a meal suppresses the gut hormone
acylated ghrelin and perceived hunger, and increases peptide
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YY (PYY) and perceived satisfaction (7). Standardized meals, as
opposed to ad libitum buffet meals, provide a fixed amount of
preselected food items and can be used to compare meal-related
outcomes when the exact same stimulus is given. Previous
studies have suggested that individuals exhibit reproducible
ad libitum energy intake, as well as changes in subjective
appetite perceptions, glucose, and appetite-related hormones, in
response to a standardized meal provided on separate occasions
(8–11). Although such efforts to explore reproducibility and
individual responses alongside the mean effects of an inter-
vention should be encouraged, there are significant method-
ological and analytical challenges to adequately quantifying
interindividual variability (1). In the context of a crossover
study, these challenges include replicating each intervention and
control condition and partitioning true response heterogeneity
from within-subjects random measurement variability with an
appropriate statistical model (1).
Current evidence is often limited by the absence of a control
group or condition,which has been highlighted as an imperative
study design feature to account for random within-subject
variability over time (1, 3, 12). A recent approach proposed
to quantify individual differences in the intervention response
involves quantifying the participant-by-response interaction
from replicated intervention and control groups or conditions
(3, 13, 14). We have recently adopted this framework to
highlight the presence of individual variability in subjective and
hormonal appetite responses to acute exercise (15); however,
it is not known whether such variability in appetite responses
exists in response to a standardized meal.
A further consideration, if true individual differences are
present, involves identifying potential moderators that could
explain the individual variability (1). The fat mass and obesity
associated (FTO) gene represents the most extensively studied
gene associated with obesity, with individuals homozygous for
the obesity risk A allele (AA) of FTO rs9939609 weighing a
mean 3 kg more and having a 1.7-fold higher obesity risk than
those homozygous for the low-risk T allele (TT) (16). Although
the physiological mechanisms underlying this heightened risk
are not fully understood, it has been demonstrated that
AA individuals exhibit a blunted postprandial suppression of
acylated ghrelin and hunger compared with adiposity-matched
TT individuals (17). Given that interindividual variability in the
responses of appetite to repeated meal intake is suspected, it is
possible that groups with different risk variants of the FTO gene
may moderate these responses.
Therefore, the aims of this study were 1) to investigate
whether the perceived appetite and appetite-related hormone
responses to a standardized meal are reproducible on repeated
occasions; 2) to examine whether there is true individual
variability in appetite responses to a standardized meal;
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and 3) to determine whether the FTO genotype moder-
ates the magnitude of appetite responses to a standardized
meal.
Methods
Ethical approval
All procedures included in this study (NCT03771690) were approved
by Loughborough University Ethics Advisory Committee. All partic-
ipants provided written informed consent before taking part in any
aspect of the study.
Participants
Participants were selected from 2 previous study databases where
participants were genotyped for the rs9939609 allele of the FTO gene.
Genomic DNA was extracted from the whole blood samples using the
QIAamp DNAMini kit (QIAGEN). The samples were genotyped using
the Applied Biosystems TaqMan (RocheMolecular Systems) genotyping
assay and real-time PCR system. Eighteen healthy white European
men were recruited for this study between January and April, 2018
according to their FTO genotype: 9 homozygous minor allele (AA)
and 9 homozygous major allele (TT) (refer to the participant flowchart
supplied in Supplemental Figure 1). Participants were informed about
the study purpose; however, their genotype was not disclosed until
the end of the study in order to avoid any potential effect on the
outcomes of interest. Participants were body-mass stable (≤3 kg change
in the previous 3 mo), nonsmokers, had no history of cardiovascular
or metabolic disease, and were not dieting or taking any medications.
Participants were habitual breakfast eaters and “moderately active”
according to the International Physical Activity Questionnaire (18),
which was used to ensure homogeneity in physical activity levels across
the study sample.
Anthropometry
Height was measured to the nearest 0.1 cm and bodymass to the nearest
0.1 kg using an electronic measuring station (Seca). BMI was calculated
as kg/m2. Skinfold thickness was measured at 3 sites (chest, abdomen,
and thigh) and body fat percentage was estimated using the equations
of Jackson and Pollock (19) and Siri (20).
Experimental design
Using a replicated crossover experimental design (3), participants
completed 4 visits in a randomized order, each separated by an interval
of ≥3 d: 2 identical fasting control and 2 identical standardized meal
conditions. The block randomization plan (21) was obtained by the
main investigator (FRG), who also enrolled participants and assigned
participants to interventions. Participants completed a weighed food
record in the 24 h preceding the first visit andwere instructed to replicate
this feeding pattern before each subsequent visit. Participants refrained
from alcohol, caffeine, and strenuous physical activity during the same
period. A standardized meal was consumed in the evening before the
laboratory visits consisting of a pizza (3054 kJ, 44% carbohydrate,
22% protein, 34% fat). Participants were instructed to consume the
whole meal without any additional food or drink items except plain
water, and compliance was confirmed from the food record completed
before the first visit, and verbally on the remaining visits. After this
meal, participants consumed no food or drink except plain water before
arriving at the laboratory the next day.
Main conditions
Participants arrived at the laboratory at 0900 after a 13-h overnight
fast. A cannula (Venflon; Becton Dickinson) was inserted into an
antecubital vein 60 min before the collection of venous blood samples
to eliminate any stress effects associated with cannula insertion (22).
A fasting venous blood sample and rating of perceived appetite were
taken at ∼1000 (0 h). Participants rested throughout all 4 conditions
but were provided with a standardized breakfast meal after the fasting
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measurements during the 2 meal conditions. Breakfast was consumed
within 15 min and consisted of croissants, butter, chocolate spread,
cereal biscuits, and milkshake which provided 5025 kJ energy (47%
carbohydrate, 9% protein, 44% fat). Subsequent venous blood samples
were taken at 0.5 and 1 h, and appetite perceptions were assessed at
1 h. Environmental temperature and humidity were monitored and kept
constant throughout all main experimental conditions using a wireless
weather station (Opes).
Subjective appetite ratings
Subjective appetite ratings [hunger, satisfaction, fullness, and prospec-
tive food consumption (PFC)] were assessed at 0 and 1 h using
100-mm visual analog scales (8) as primary study outcomes. The scales
were anchored by a descriptor at each end defining the extremes of the
appetite perception being measured.
Blood sampling and biochemical analysis
Venous blood samples were collected in the semisupine position for
the measurement of plasma acylated ghrelin, total PYY, insulin, and
glucose concentrations as primary study outcomes. Plasma acylated
ghrelin and total PYY concentrations were quantified from samples at
0 and 1 h, and plasma insulin and glucose concentrations were measured
at 0 and 0.5 h to capture the peak change in concentration after the
meal.
Venous blood samples were collected into prechilled 4.9-mL EDTA-
coated monovettes (Sarstedt) for the determination of plasma acylated
ghrelin concentrations, and into 9-mL EDTA-coated monovettes
(Sarstedt) for the determination of total PYY, insulin, and glucose
plasma concentrations. The blood processing methods have been
detailed previously elsewhere (23, 24). Duplicate hemoglobin and
hematocrit measurements were taken at each blood sampling time point
to calculate the acute change in plasma volume (25). Commercially
available enzyme immunoassays were used to determine the plasma con-
centrations of acylated ghrelin (Bertin Pharma), total PYY (Millipore),
and insulin (Mercodia). Plasma glucose concentrations were analyzed
by enzymatic, colorimetric methods using a benchtop analyzer (Pentra
400, HORIBA Medical). All samples were analyzed in duplicate and,
in order to eliminate interassay variation, samples for each participant
were analyzed in the same run. The within-batch CV values for acylated
ghrelin, total PYY, insulin, and glucose concentrations were 4.0%,
4.6%, 5.9%, and 0.4%, respectively.
Statistical analyses
In our previous replicated crossover study (15), we detected statistically
significant participant-by-treatment interactions with a sample size of
15 participants. Based on information from this study, we assumed
a correlation between trials of 0.7. Using G∗Power version 3.1.9.2
(University of Kiel), it was estimated that a total sample size of
16 participants would provide 80% statistical power to detect a
statistically significant interaction between our 2-level between-subjects
factor of genotype and within-subjects factor of treatment effect when
this interaction amounted to a standardized effect size (ES) of 0.2
(α = 0.05). The 4 measurements of each outcome associated with our
replicated crossover design increase statistical power over a conven-
tional 2-level crossover study for detection of this group-by-treatment
interaction.
Between-genotype differences in participant characteristics were
quantified using linear mixed models with group (AA compared
with TT) modelled as a fixed factor. The presence of interindividual
differences in responses of appetite-related blood parameters and
perceived appetite to a standardized meal was examined according to
3 analytical approaches (1, 3, 13). The 3 approaches, detailed recently
by Goltz et al. (15), were as follows:
1) The association between the first and second replicate of the
control-adjusted treatment effect was quantified for each outcome
using Pearson’s product-moment correlation coefficients (3). The
first meal condition in any participant’s sequence was paired
to the first control condition in the same individual’s sequence.
Thresholds of 0.1, 0.3, and 0.5 were used to label correlation
coefficients as small, moderate, and large, respectively (26). This
correlation coefficient quantifies the consistency of meal effect
across the replicated experimental conditions.
2) The following equation (1) was used to provide an overall
estimate of the true (control condition–adjusted) between-subject
differences in treatment response:
SDIR =
√
SD2M − SD2C (1)
SDIR represents the true interindividual variation in treatment
effect. SDM and SDC are the SDs of the pre-to-post change scores
for the meal and fasting control conditions [averaged over the
2 replicates using the relevant equation for pooling SDs (27)].
3) Although the equation in 2) estimates response variance adjusted
for control condition change variance, the associated SEs and
CIs are not appropriate for our within-subjects crossover study
design, hence our adjunct approach of within-subjects general
linear modelling. Using theMIXED procedure in SASOnDemand
for Academics (SAS Institute) (28), a within-participant linear
mixed model was formulated to quantify any participant-by-
condition interaction for each outcome. Condition and period
(sequence), and their interaction effects, were modelled as fixed
effects, and participant and participant-by-condition terms were
modelled as random effects (refer to the SAS code supplied
in Supplemental Methods). Standard residual diagnostics were
undertaken to assess the “influence diagnostics” of a potential set
of observations on the adequacy and the stability of the modelled
covariance parameter estimates (29–31).
The grand mean differences between conditions and associated 95%
CIs were quantified with a within-subjects linear mixed model run
in SPSS version 23 (IBM Corporation) without the participant-by-
condition random effect, but with a covariate of baseline values. The
FTO genotype was included in this model as a fixed between-subjects
effect, and the genotype-by-condition interaction was quantified.
Correction of hormone and glucose concentrations for acute
changes in plasma volume had a negligible influence on our findings
and, therefore, the unadjusted plasma concentrations are displayed
for simplicity. In the absence of a robust and precise prognostic
anchor for an important difference in our appetite-related outcomes,
we calculated distribution-based standardized ESs (32). An ES of 0.2
denoted the minimum important mean difference for all outcomes,
with an ES of 0.5 being moderate and an ES of 0.8 being large (26).
To calculate the minimal clinically important difference (MCID) for
individual responses, the threshold of 0.2 for interpreting standardized
mean changes (26) was halved, i.e., 0.1, and multiplied by the baseline
between-subject SD (1, 33). Pearson’s product-moment correlation
coefficients were quantified between the mean control-adjusted meal
response for each of the appetite measures and body adiposity
measurements. Correlation coefficients were also quantified between
the pooled mean pre-to-post change in concentrations of plasma
constituents and the pooled mean pre-to-post change in appetite
perceptions across the 4 conditions.
Data are presented as mean ± SD. Mean differences or changes and
correlation coefficients are presented along with their respective 95%
CIs. Statistical significance was accepted as P < 0.05 and P values are
expressed in exact terms apart from for very low values, which are
expressed as P < 0.001.
Results
Participant characteristics
Participant characteristics are presented in Table 1. All 95%
CIs for the difference between AAs and TTs overlapped zero
(P ≥ 0.41), although these 95% CIs were relatively wide.
All standardized ESs were very small, except for the small-
to-moderate ESs found for body fat percentage and fat-free
mass.
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TABLE 1 Participant characteristics1
All
(n= 18)
FTO homozygous
minor allele (AA)
(n= 9)
FTO homozygous
major allele (TT)
(n= 9)
AA vs. TT mean
difference
(95% CI) ES
Age, y 28.5 ± 9.8 28.5 ± 9.6 28.4 ± 10.5 0.1 (−9.9, 10.2) 0.01
Height, m 1.78 ± 0.06 1.78 ± 0.07 1.78 ± 0.05 − 0.002 (−0.06, 0.06) 0.03
Body mass, kg 85.5 ± 16.0 85.7 ± 14.2 85.3 ± 18.5 0.4 (−16.1, 16.9) 0.03
BMI, kg/m2 27.0 ± 5.0 27.1 ± 4.7 26.8 ± 5.6 0.2 (−4.9, 5.4) 0.05
Body fat percentage, % 20.2 ± 9.1 18.9 ± 9.1 21.4 ± 9.5 − 2.6 (−11.8, 6.7) 0.27
Fat-free mass, kg 67.1 ± 7.8 68.7 ± 8.8 65.5 ± 6.8 3.1 (−4.7, 11.0) 0.40
1Values are means ± SDs, n = 18 healthy men (9 AA, 9 TT). ES, standardized effect size (mean difference); FTO, fat mass and obesity associated gene.
Plasma hormone and metabolite concentrations
Acylated ghrelin.
A weak correlation was observed between the 2 repli-
cates of control-adjusted meal responses for acylated ghrelin
(r = 0.22, 95% CI: −0.27, 0.62, P = 0.38, Figure 1A).
In agreement with our postestimation residuals diagnostics,
2 distinct outliers can be seen in Figure 1A, which were
>3 times higher or lower than the sample SD. Although
we explored several data transformations, these were not
successful in improving the nonnormal distribution of the
ghrelin data. We could not identify any systematic protocol
variation or measurement issues that would explain these
2 outliers. The removal of the 2 outliers in a sensitivity analysis
improved the correlation coefficient of treatment effect between
replicates to 0.86 (95% CI: 0.64, 0.95, P < 0.001). The
SD of within-trial change was substantially greater for the
meal than for the control conditions and remained so after
removal of the 2 outliers (Table 2). After adjustment for period
(sequence) influences, the estimated marginal mean acylated
ghrelin concentration was 62 pg/mL lower (95% CI: −69,
−54 pg/mL, P < 0.001, ES = 0.18) in the meal than in
the control conditions. The P value for the participant-by-
condition interaction was just above the threshold for statistical
significance after the removal of the 2 outliers (Table 2). The
magnitude of change in individual replicated mean responses
after the meal for acylated ghrelin ranged from −128 to
−38 pg/mL, with all participants demonstrating a meal-
mediated suppression of ghrelin beyond the MCID (±34.8
pg/mL) (Figure 2A).
Total PYY.
A large positive correlation of 0.50 (95% CI: 0.04, 0.78,
P = 0.034) was observed between the 2 replicates of control-
adjusted meal responses for total PYY (Figure 1B). The within-
trial SD for total PYYwas substantially greater for themeal than
for the control conditions (Table 2). The period-adjusted mean
total PYY concentration was 78 pg/mL higher (95% CI: 70,
87 pg/mL, P< 0.001, ES = 1.96) in the meal than in the control
conditions. A statistically significant participant-by-condition
interaction was found (Table 2). The magnitude of change in
individual replicated mean responses after the meal for total
PYY ranged from 15 to 115 pg/mL, with all participants
demonstrating an increase beyond the MCID (±3.99 pg/mL)
(Figure 2B).
Insulin.
A large positive correlation of 0.64 (95% CI: 0.25, 0.85,
P = 0.004) was observed between the 2 replicates of control-
adjusted meal responses for insulin (Figure 1C). After our
residuals diagnostics, we undertook a sensitivity analysis where
we removed 1 outlier, which was >4 times higher than the
sample SD. This improved the correlation to 0.82 (95% CI:
0.56, 0.93, P < 0.001). The within-trial SD for insulin was
substantially greater for the meal than for the control conditions
(Table 2). The period-adjusted mean insulin concentration was
526 pmol/L higher (95% CI: 442, 610 pmol/L, P < 0.001,
ES = 21.60) in the meal than in the control conditions. The
participant-by-condition interaction was statistically significant
both with and without inclusion of the outlier (Table 2). The
magnitude of change in individual replicated mean responses
after the meal for insulin ranged from 123 to 1130 pmol/L, with
all participants demonstrating an increase beyond the MCID
(±2.43 pmol/L) (Figure 2C).
Glucose.
A moderate positive correlation of 0.44 (95% CI: −0.03, 0.75,
P = 0.07) was observed between the 2 sets of control-adjusted
meal responses for glucose (Figure 1D). The within-trial SD
for glucose was substantially greater for the meal than for
the control conditions (Table 2). The period-adjusted mean
glucose concentration was 1.30 mmol/L higher (95% CI: 1.14,
1.46 mmol/L, P < 0.001, ES = 3.61) in the meal than in
the control conditions. The participant-by-condition interaction
was statistically significant (Table 2). The magnitude of change
in individual replicated mean responses after the meal for
glucose ranged from 0.52 to 2.39 mmol/L, with all participants
demonstrating an increase beyond the MCID (±0.04 mmol/L)
(Figure 2D).
Subjective appetite ratings
Moderate-to-large positive correlations were observed between
the 2 sets of control-adjusted meal responses for hunger
(r= 0.59, 95%CI: 0.17, 0.83,P= 0.010), satisfaction (r= 0.74,
95% CI: 0.42, 0.90, P < 0.001), fullness (r = 0.41, 95%
CI: −0.07, 0.73, P = 0.09), and PFC (r = 0.65, 95% CI:
0.26, 0.86, P = 0.003) (Figure 3). Removal of 1 outlier for
fullness improved the correlation coefficient to 0.62 (95% CI:
0.22, 0.84, P = 0.008). The within-trial SD was substantially
greater for the meal than for the control conditions for hunger,
satisfaction, fullness, and PFC (Table 2).
For all perceived appetite variables, the participant-by-
condition interaction was statistically significant (Table 2).
Exclusion of the previously mentioned outlier for fullness
did not affect the significance of the participant-by-condition
interaction or the estimated individual differences SD and
therefore the data for fullness are presented with the outlier.
The period-adjusted mean ratings of hunger and PFC were
49 mm (95% CI: −53, −44 mm, P < 0.001, ES = 2.16) and
43 mm (95% CI: −48, −38 mm, P < 0.001, ES = 4.26)
lower, respectively, in the meal than in the control conditions.
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FIGURE 1 Correlation between meal (standardized meal providing 5025 kJ) and control (no intervention) pre-to-post change scores on the
2 occasions for plasma acylated ghrelin (A), plasma total PYY (B), plasma insulin (C), and plasma glucose (D) in 18 healthy men genotyped for
the rs9939609 allele of the fat mass and obesity associated (FTO) gene (n = 9 AA, n = 9 TT). “Response 1” corresponds to the first pair of
conditions (meal 1 minus control 1) and “response 2” to the second pair of conditions (meal 2 minus control 2). Dashed lines represent the
mean responses. PYY, peptide YY.
The period-adjusted mean ratings of satisfaction and fullness
were 52 mm (95% CI: 47, 56 mm, P < 0.001, ES = 3.46)
and 51 mm (95% CI: 45, 57 mm, P < 0.001, ES = 3.23)
higher, respectively, in the meal than in the control conditions.
The magnitude of change in individual replicated mean
responses after the meal ranged from −97 to 14 mm for
hunger, 11 to 88 mm for satisfaction, 13 to 89 mm for
fullness, and −96 to −4 mm for PFC. All participants
demonstrated a response beyond the MCID for hunger
(±2.27 mm), satisfaction (±1.49 mm), fullness (±1.59 mm),
and PFC (±1.59 mm) (Figure 4).
Moderating effect of FTO genotype on individual
variability
The FTO genotype-by-condition interaction was statistically
nonsignificant for acylated ghrelin (P = 0.42), total PYY
(P = 0.19), insulin (P = 0.54), glucose (P = 0.70), and all
of the perceived appetite ratings (P ≥ 0.47). The differences
in the mean treatment effects observed for all appetite pa-
rameters between genotype groups were small and statistically
nonsignificant (ES ≤ 0.27, P ≥ 0.17). The upper confidence
limit of the FTO gene difference was also only small to
moderate.
Correlations between appetite outcomes and
individual characteristics
Large positive correlations were observed between mean
acylated ghrelin control-adjusted meal responses and bodymass
(r = 0.55, P = 0.019), BMI (r = 0.56, P = 0.015), and
body fat percentage (r = 0.56, P = 0.016). Large positive
correlations were also observed between hunger mean responses
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TABLE 2 Means and SDs of the pre-to-post change scores for the meal (standardized meal providing 5025 kJ) and control (no
intervention) conditions and the true individual differences SD1
Estimate 12 Estimate 23
Variable
Meal change,
mean ± SD
Control change,
mean ± SD
Individual
differences, SD
Individual
differences, SD (SE) P value
Plasma acylated ghrelin, pg/mL − 61.1 ± 36.2 6.2 ± 27.7 23.3 4.9 (16.1) 0.93
− 57.0 ± 20.44 7.4 ± 12.54 16.24 18.0 (13.0)4 0.0564
Plasma total PYY, pg/mL 61.6 ± 35.1 − 13.9 ± 11.1 33.3 31.8 (20.6) 0.020
Plasma insulin, pmol/L 545 ± 324 0.1 ± 11.5 324 502 (300) 0.005
515 ± 2874 0.0 ± 11.84 2864 349 (208)4 0.0054
Plasma glucose, mmol/L 1.22 ± 0.62 − 0.09 ± 0.17 0.60 0.58 (0.37) 0.012
Hunger, mm − 40.4 ± 30.0 8.7 ± 15.2 25.9 22.7 (15.4) 0.031
Satisfaction, mm 48.3 ± 24.0 − 3.0 ± 9.4 22.0 19.5 (12.7) 0.018
Fullness, mm 52.8 ± 20.2 1.4 ± 12.3 16.0 13.6 (9.8) 0.054
Prospective food consumption, mm − 44.1 ± 27.8 2.2 ± 9.8 26.0 23.9 (15.3) 0.015
1Data are presented for n = 18 healthy men. PYY, peptide YY.
2Estimate 1: individual differences SD estimated using SDIR =
√
SD2M − SD2C where SDIR is the SD of the true individual response, and SDM and SDC are the SDs of the
pre-to-post change scores for the meal and the control condition (averaged over both replicates), respectively (1).
3Estimate 2: period-adjusted individual differences SD estimated using a random-effects statistical model (13). The SD was derived from the SAS model participant-by-condition
interaction term (as a random effect) (refer to the SAS code supplied in the Supplemental Methods). The P value shown is also for this interaction term.
4After the removal of outliers.
and BMI (r = 0.53, P = 0.023) and body fat percentage
(r= 0.55,P= 0.018).None of the remaining appetite parameter
mean responses were significantly correlated with the adiposity
parameters assessed in this study (r = −0.46 to 0.41, P ≥ 0.06).
No significant correlations were observed between fat-free mass
and any of the mean appetite parameter responses to the meal
(r = −0.14 to 0.36, P ≥ 0.15).
Correlations between changes in study outcome
variables
A large positive correlation was observed between the pre-
to-post change in acylated ghrelin and the change in both
hunger and PFC, whereas a large negative correlation was
observed between the pre-to-post change in acylated ghrelin and
the change in both satisfaction and fullness. A large negative
correlation was observed between the pre-to-post change in
total PYY and the change in both hunger and PFC, whereas a
large positive correlation was observed between the pre-to-post
change in total PYY and the change in both satisfaction and
fullness. A moderate negative correlation was observed between
the pre-to-post change in insulin and the change in both hunger
and PFC, whereas moderate-to-large positive correlations were
observed between the pre-to-post change in insulin and the
change in both satisfaction and fullness. A large negative
correlation was observed between the pre-to-post change in
glucose and the change in both hunger and PFC, whereas a
large positive correlation was observed between the pre-to-
post change in glucose and the change in both satisfaction and
fullness (refer to results presented in Supplemental Table 1).
Discussion
The main findings from our study are that control-adjusted
appetite-related blood parameters and perceived appetite re-
sponses to a standardized meal are reproducible when measured
on 2 separate occasions. True interindividual variability exists
in the postmeal responses of all studied outcomes, but we did
not detect any worthwhile or statistically significant moderating
influence of the FTO genotype on the magnitude of postmeal
responses.
As expected, meal intake after an overnight fast resulted
in mean suppressions of acylated ghrelin, hunger, and PFC,
concomitantly with increases in total PYY, insulin, glucose,
fullness, and satisfaction. Correlation coefficients between the
2 replicates of control condition–adjusted responses were
positive, significant, and large for total PYY, insulin, hunger,
satisfaction, and PFC. The correlation for acylated ghrelin was
positive, but small and nonsignificant.However, the exclusion of
2 outliers improved the correlation markedly and we could not
identify any methodological factors that could explain the one-
off large or small values. Correlation coefficients for glucose and
fullness were positive and moderate, although nonsignificant.
Removal of 1 outlier for fullness improved the correlation.
Overall, the postprandial changes in appetite parameters were
similar between the 2 experiment replicates, suggesting good
reproducibility of appetite responses to meal intake.
Previous studies have also reported good reproducibility of
ad libitum energy intake, cholecystokinin, glucose, insulin (9,
11), and appetite perceptions after repeated fixed test meals (8,
10, 11). Although Nair et al. (9) observed good reproducibility
of blood glucose AUC after a glucose preload on 3 occasions,
the time taken for glucose to peak varied between visits. In
our study, the pre-to-post change score was calculated between
the fasting state and a single postprandial time point when
the peak postmeal change was expected. It is possible that the
relatively small correlation for pre-to-post changes in glucose on
2 occasions reflects inconsistency in the time taken for glucose
to peak after a meal for some participants, rather than a lack of
reproducibility of the response magnitude per se.
Recently, Gonzalez et al. (34) observed poor reproducibility
at the individual level in perceived appetite after the consump-
tion of liquid meals. Data were pooled from 2 previous studies
comparing low- and high-energy liquid meals, but no control
condition was included. The inclusion of a condition where
no intervention takes place is essential so that the natural
oscillation in the outcomes can be quantified and, therefore,
the “true” effect of the intervention can be assessed (1, 3). Our
results indicate that, besides the good reproducibility of appetite
responses to meal intake, the magnitude of change varied
considerably between individuals, supported by the participant-
by-condition interactions. No previous studies have examined
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FIGURE 2 Individual changes in hormone and glucose concentrations between the meal (standardized meal providing 5025 kJ) and control
(no intervention) conditions (meal minus control): plasma acylated ghrelin (A), plasma total PYY (B), plasma insulin (C), and plasma glucose (D) in
18 healthy men genotyped for the rs9939609 allele of the fat mass and obesity associated (FTO) gene (n = 9 AA, n = 9 TT). Pre-to-post change
scores for “response 1” and “response 2” are indicated by white and black circles. Gray lines (—) represent each participant’s replicated mean
response. Dashed lines indicate the standardized minimal clinically important difference, calculated as 0.1 × the baseline between-subject SD.
PYY, peptide YY.
the interindividual variability in appetite responses to a meal
including control conditions in a replicated crossover design.
Therefore, our study adds to the literature by using a novel and
appropriate study design and statistical analysis approach (1,
3).
The SD of the pre-to-post change scores was substantially
larger in the meal than in the control conditions, indicating
that the individual differences could not be explained by
random within-subject variation or measurement errors (1). All
participants exhibited perceived appetite and appetite-related
blood parameter responses beyond our defined MCIDs, but a
few participants were “small responders,” whereas others were
“very large responders” according to the degree of change in
the appetite parameters after meal intake. Of note, there are
no clinically relevant target differences established for appetite
parameters and the MCID thresholds chosen were based on the
statistical threshold of 0.1 SD for judging clinical importance
of individual differences. Clinically relevant differences are
most appropriately defined using “hard” anchors to changes
in morbidity and/or mortality (32), but information is lacking
on this at present. All participants exhibited the expected
direction of meal-induced change in the various outcomes, i.e.,
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FIGURE 3 Correlation between meal (standardized meal providing 5025 kJ) and control (no intervention) pre-to-post change scores on the
2 occasions for hunger (A), satisfaction (B), fullness (C), and PFC (D) in 18 healthy men genotyped for the rs9939609 allele of the fat mass and
obesity associated (FTO) gene (n = 9 AA, n = 9 TT). “Response 1” corresponds to the first pair of conditions (meal 1 minus control 1) and
“response 2” to the second pair of conditions (meal 2 minus control 2). Dashed lines represent the mean responses. PFC, prospective food
consumption.
suppression of acylated ghrelin, hunger, and PFC and increase
in total PYY, insulin, glucose, fullness, and satisfaction, except
for 1 participant who exhibited an increase in hunger after meal
intake on both occasions.
The FTO genotype-by-condition interaction was statistically
nonsignificant for all of the appetite parameters. Although
statistical power can be lower for the detection of subgroup-
by-treatment interactions than for the overall treatment effect,
ESs were low for all FTO gene subgroup interaction terms.
It is well established that the homozygous AA variant of the
FTO genotype confers a higher obesity risk (16). Although
the mechanisms are not fully elucidated, it has been suggested
that AAs demonstrate attenuated postprandial suppression of
acylated ghrelin and hunger (17). In contrast, a recent study did
not identify differences in hunger or total ghrelin between FTO
genotype groups in individuals with overweight or obesity after
standardized and buffet meals, even though AAs had higher
energy intake at the buffet meal (35). Of note, the assessment
of total ghrelin in this study could have influenced the results
as the active part of the hormone only represents ∼5–10%
of total ghrelin (36, 37). Longer-term studies are needed to
confirm whether differences in appetite-related outcomes are
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FIGURE 4 Individual changes in each appetite perception between themeal (standardizedmeal providing 5025 kJ) and control (no intervention)
conditions (meal minus control): hunger (A), satisfaction (B), fullness (C), and PFC (D) in 18 healthy men genotyped for the rs9939609 allele of
the fat mass and obesity associated (FTO) gene (n= 9 AA, n= 9 TT). Pre-to-post change scores for “response 1” and “response 2” are indicated
by white and black circles. Gray lines (—) represent each participant’s replicated mean response. Dashed lines indicate the standardized minimal
clinically important difference, calculated as 0.1 × the baseline between-subject SD. PFC, prospective food consumption.
observed between FTO genotype groups which may culminate
in continuous differences in energy intake, and consequently,
body mass alterations.
Exploratory analyses of our data indicated that higher
adiposity was associated with smaller changes in the mean
postprandial acylated ghrelin and hunger responses, supporting
previous evidence suggesting that individuals with obesity
exhibit a reduced postprandial suppression of ghrelin (38).
However, our study was not designed to answer this question
and participant recruitment aimed to match the 2 FTO-
genotype groups for age and adiposity. Besides adiposity
levels, individual differences in rates of stomach distention and
gastric emptying (39), as well as differences in gut microbiota,
could potentially explain the interindividual variability in
postprandial appetite responses (40). Indeed, direct associations
between insulin and glucose responses to a glucose preload
and rates of gastric emptying have been observed (9), and
a growing body of evidence points to the important role of
the gut microbiota in nutrient sensing and appetite regulation
(40, 41). Future research is required to determine moderators
of appetite responses to meal intake that may explain the
individual variability.
All the correlations between the changes in perceived
appetite and appetite-related blood parameters were significant
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apart from the correlations between insulin and hunger,
satisfaction, and PFC. Although the exact pathways are unclear,
insulin has been associated previously with short-term appetite
control in healthy individuals, with evidence demonstrating that
higher postprandial insulin concentrations were associated with
greater sensations of satiety and lower sensations of hunger (42).
Overall, our results provide evidence of very strong associations
between perturbations in appetite-related blood parameters
and perceived sensations of hunger, satisfaction, fullness, and
PFC. This supports previous evidence showing that changes in
glucose, insulin, acylated ghrelin, PYY3–36, and glucagon-like
peptide-1 concentrations occur synchronously with changes in
perceived appetite after the consumption of test meals (43).
The strengths of our study include the novel study design and
statistical approaches employed, which have been advocated
to quantify interindividual variability in responses to an
intervention appropriately (1, 3). Furthermore, the combination
of circulating blood parameters with perceived appetite ratings
known to respond episodically to meal intake represents a
further strength. Care should be taken when generalizing
the findings because alternative blood processing or analysis
methods, as well as inclusion of females, older individuals, and
individuals with obesity, may result in different findings.
In conclusion, the reproducibility of appetite responses
to standardized meals is generally good. True interindividual
variability is present in appetite-related blood parameter
responses and perceived appetite responses to meal intake
beyond any random within-subject variation over time in
healthy men, but the magnitude of change in postprandial
appetite responses was not influenced by the FTO gene. Our
study supports the existence of true interindividual variability
in postprandial appetite changes between individuals, which
should be considered in future research as well as for interpret-
ing group mean results from intervention studies. Furthermore,
these findings highlight the importance of exploring individual
differences in appetite response in the context of the prevention
and treatment of obesity. Further studies with longer-term
interventions using appropriate study designs and statistical
analyses are needed to identify potential moderators responsible
for the individual variability in postprandial appetite responses
and to confirm the exact clinical relevance of our findings.
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